Fetal exposure to tobacco smoke products: A comparison between self-reported maternal smoking and concentrations of cotinine and thiocyanate in cord serum

Acta Obstetricia et Gynecologica Scandinavica

Volumn 75, Issue 10, 1996, Pages 902-907

  Nafstad, Per ^a   Kongerud, Johny ^b   Botten, Grete ^a   Urdal, Petter ^c   Silsand, Terje ^d   Pedersen, Babill Stray ^e   Jaakkola, Jouni J K ^a,f  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^d TELEMARK HOSPITAL   (Norway)

^e AKER UNIVERSITY HOSPITAL   (Norway)

^f UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Cotinine; Fetus; Thiocyanate; Tobacco smoke exposure; Umbilical cord blood

Indexed keywords

BIOLOGICAL MARKER; COTININE; THIOCYANATE; TOBACCO SMOKE;

ADULT; ARTICLE; CIGARETTE SMOKING; COMPARATIVE STUDY; CONTROLLED STUDY; CORD SERUM; FEMALE; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; PRENATAL EXPOSURE; PRIORITY JOURNAL; QUESTIONNAIRE; REGRESSION ANALYSIS; SELF REPORT; SMOKING HABIT;

EID: 0030476456     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.3109/00016349609055025     Document Type: Article

References (25)

1. Kramer MS. Determinants of low birth weight: methodological assessment and meta-analysis. Bulletin of the World Health Organization 1987; 65 (5): 663-737.
2. Martin TR, Bracken MB. Association of low birth weight with passive smoke exposure in pregnancy. Am J Epidemiol 1986; 124: 633-42.
3. Magnusson CGM. Maternal smoking influences cord serum IgE and IgD levels and increases the risk for subsequent infant allergy. J Allergy Clin Immunol 1986; 91: 898-904.
4. Hanrahan JR, Tager IB, Segal MR, Tosteson TD, Castile RG, Vunakis HV et al. The effect of maternal smoking during pregnancy on early infant lung function. Am Rev Respir Dis 1992; 145: 1129-35.
5. Respiratory-health effects of passive smoking: lung cancer and other disorders. United States Environmental Protection Agency. EPA/600\6-90\006F.Washington DC 1992.
6. Bottoms SF, Kuhnert BR, Kuhert PM, Reese AL. Maternal passive smoking and fetal thiocyanate levels. Am J Obstet Gynecol 1982; 144: 787-91.
7. Luck W, Nau R, Hansen R, Steldinger R. Extent of nicotine and cotinine transfer to the human fetus, placenta and amniotic fluid of smoking mothers. Dev Pharmacol Ther 1985; 8: 384-95.
8. Sorsa M, Husgafvel-Pursiainen K. Assessment of passive and transplacental exposure to tobacco smoke. IARC Sci Publ 1988; 89: 129-32.
9. Donnenfeld AK, Pulkkinen A, Palomaki GE, Knight GJ, Haddow JE. Simultaneous fetal and maternal cotinine levels in pregnant women smokers. Am J Obstet Gynecol 1993; 168: 781-2.
10. Ownsby DR, Johnson CC, Peterson EL. Maternal smoking does not influence cord serum IgE or IgD concentrations. J Allergy Clin Immunol 1991; 88: 555-60.
11. Oryszczyn MP, Godin J, Annesi I, Hellier G, Kauffmann F. In utero exposure to paternal smoking, cotinine measurements, and cord blood IgE. J Allergy Clin Immunol 1991; 87: 1169-74.
12. Perez-Stable EJ, Marin G, Marin BV, Benowitz NL. Misclassification of smoking status by self-reported cigarette consumption. Am Rev Respir Dis 1992; 145: 53-7.
13. Jarvis MJ, Tunstall-Pedoe H, Feyerabend C, Vesey C, Salloojee Y. Comparison of tests used to distinguish smokers from nonsmokers. Am J Public Health 1987: 77: 1435-8.
14. Wagenknecht LE, Burke GL, Perkins LL, Haley NJ, Friedman GD. Misclassification of smoking status in the CARDIA study: A comparison of self-report with serum cotinine levels. Am J Public Health 1992; 82: 33-6.
15. Murray RP, Connett JE, Lauger GG, Voelker HT. Error in smoking measures: effects of intervention on relations of cotinine and carbon monoxide to self-reported smoking. Am J Public Health 1993; 83: 1251-7.
16. Borgers D, Junge B. Thiocyanate as an indicator of tobacco smoking. Prev Med 1979; 8: 351-7.
17. Waage H, Silsand T, Urdal P, Langård S. Discrimination of smoking status by thiocyanate and cotinine in serum, and carbon monoxide in expired air. Int J Epidemiol 1992; 21: 488-93.
18. Nafstad P, Oie L, Kongerud J, Botten G. Exposure assessments in the Oslo Environment and Childhood Asthma Study. Proceedings of Indoor Air '93; 1: 809-14.
19. Degiampietro P, Peheim E. Determination of thiocyanate in plasma and saliva without deproteinisation and its validation as a smoking parameter. J Clin Chem Clin Biochem 1987; 25: 711-7.
20. Cook RD. Detection of influential observation in linear regression. Technometrics 1977; 19: 15-8.
21. SPSS for Windows. Release 6.0. SPSS Inc. Chicago, USA.
22. Foss OP, Lund-Larsen PG. Serum thiocyanate and smoking: interpretation of serum thiocyanate levels observed in a large health study. Scand J Clin Lab Invest 1986; 46: 245-51.
23. Haug K, Foss OP, Kvamme JM. Do pregnant women who report a reduction in cigarette consumption consume less tobacco? Scand J Prim Health Care 1994; 12: 269-75.
24. Martinez FD, Wright AL, Taussig LM, GHMA. The effect of paternal smoking on the birthweight of newborns whose mothers did not smoke. Am J Public Health 1994; 84: 1489-91.
25. Cummings SR, Richard RJ. Optimum cutoff points for biochemical validation of smoking status. Am J Public Health 1988; 78(5): 574-5.